Coverage
-
September 19, 2017
Drug companies AstraZeneca and Amneal have settled a patent infringement lawsuit over Amneal's application to sell a generic version of AstraZeneca diabetes drug Byetta, according to a Monday filing in Delaware federal court.
1 other articles on this case.
View all »